Curi Wealth Management, LLC Precision Biosciences Inc Transaction History

Curi Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$0.29 - $0.45 $63 - $99	220 Added 0.06%	340,021 $122,000
Q3 2023 Nov 06, 2023	BUY	$0.34 - $0.69 $34,180 - $69,365	100,530 Added 42.02%	339,801 $115,000
Q2 2023 Jul 31, 2023	SELL	$0.52 - $0.91 $40,480 - $70,841	-77,848 Reduced 24.55%	239,271 $126,000
Q1 2023 May 03, 2023	BUY	$0.7 - $1.41 $109 - $219	156 Added 0.05%	317,119 $237,000
Q4 2022 Feb 03, 2023	BUY	$0.97 - $45.0 $24,250 - $1.13 Million	25,000 Added 8.56%	316,963 $377,000
Q3 2022 Nov 08, 2022	SELL	$1.22 - $40.8 $139,456 - $4.66 Million	-114,309 Reduced 28.14%	291,963 $380,000
Q2 2022 Aug 08, 2022	BUY	$1.15 - $3.34 $467,212 - $1.36 Million	406,272 New	406,272 $650,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $584M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Curi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Curi Wealth Management, LLC with notifications on news.